Although high dose oxytocin reduced the frequency of chorioamnionitis for people with a BMI < 30 kg/m2, there were no treatment effects for the outcomes of cesarean delivery, endometritis, postpartum hemorrhage, or a severe morbidity composite for people with a BMI ≥ 30 kg/m2 [27]. This evidence concerns the gene OXT and endometritis.